What is Niraparib? Niraparib is an oral medication classified as a PARP inhibitor (Poly ADP-ribose polymerase inhibitor). It works by blocking the repair of damaged DNA in cancer cells, which…
Gilteritinib: Targeted Therapy for FLT3-Mutated AML Gilteritinib is a breakthrough oral medication used in the treatment of acute myeloid leukemia (AML), specifically for patients with a FLT3 gene mutation. As…
Glecaprevir and Pibrentasvir: A Breakthrough Treatment for Hepatitis C Glecaprevir and Pibrentasvir are a powerful combination of antiviral medications used to treat chronic hepatitis C virus (HCV) infection in adults…
Acalabrutinib: Uses, Benefits, Dosage, Side Effects & More Acalabrutinib is a next-generation Bruton tyrosine kinase (BTK) inhibitor used primarily in the treatment of certain types of blood cancers. Marketed under…
Reviews
There are no reviews yet.